JEFFERY PARKER: Open Payments
NPI 1487224036 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 44 payments from 12 companies in 2025. Trend: 2023 $636 · 2024 $979 · 2025 $919
Food & beverage: $819Education: $100
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 9 | $225 |
| Janssen Biotech, Inc. | 7 | $203 |
| ABBVIE INC. | 12 | $146 |
| UROGEN PHARMA, INC. | 4 | $97 |
| PFIZER INC. | 3 | $73 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $62 |
| 180 Medical, Inc. | 1 | $28 |
| TOLMAR, INC. | 1 | $21 |
| Teleflex LLC | 1 | $19 |
| IMMUNITYBIO, INC. | 1 | $16 |
Products named: ERLEADA, GEMTESA, ORGOVYX, LUPRON DEPOT, XTANDI, PYLARIFY, BOTOX, JELMYTO.
Industry payments across KS — which companies pay providers there.
